Search company, investor...

Founded Year

2010

Stage

Seed VC | Alive

Total Raised

$1.02M

Last Raised

$1M | 12 yrs ago

About CellScope

CellScope is a mobile-health startup developing a smartphone-enabled otoscope for the remote diagnosis of pediatric ear infections. Using smartphone cameras connected to a web platform, Cellscope is creating a digital first aid kit. The company was founded in 2010 and is based in Oakland, California.

Headquarters Location

5537 Claremont Avenue #1

Oakland, California, 94618,

United States

510-282-0674

Loading...

Loading...

Research containing CellScope

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned CellScope in 1 CB Insights research brief, most recently on Aug 3, 2021.

CellScope Patents

CellScope has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/5/2014

9/20/2016

Auditory system, Ear, Image processing, Microscopy, Magnetic resonance imaging

Grant

Application Date

9/5/2014

Grant Date

9/20/2016

Title

Related Topics

Auditory system, Ear, Image processing, Microscopy, Magnetic resonance imaging

Status

Grant

Latest CellScope News

Otoscope Global Market Report 2023

Jul 25, 2023

" - https://www.reportlinker.com/p06480056/?utm_source=GNW KG, Olympus Optical Co. Ltd., Midmark Corporation, CellScope Inc., Inventis SRL, Zhejiang Honsun Medical Instrument Co. Ltd., Firefly Global, and Interacoustics A/S. The global otoscopes market is expected to grow from $2.87 billion in 2022 to $3.02 billion in 2023 at a compound annual growth rate (CAGR) of 5.4%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many every markets across the globe. The otoscopes market is expected to reach $3.64 billion in 2027 at a CAGR of 4.7%. The otoscope market consists of the sale of pneumatic otoscopes, traditional otoscopes, operating otoscopes, and fibre-optic otoscopes.Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. An otoscope is a medical device used for examining the ear. It consists of a light source, usually an LED, and a magnifying lens that allows healthcare professionals to visualize the ear canal and eardrum. North America was the largest region in the otoscope market in 2022.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in otoscope report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The main types of otoscopes are pocket otoscope, full sized otoscope, and video otoscope.A pocket otoscope refers to a smaller, portable version of an otoscope that is designed to be compact and convenient for carrying in a pocket or medical bag and used for examining the ears by healthcare professionals in clinical settings or during house calls. They are manufactured by modality including wired digital and wireless along with their portability of including it as wall mounted and portable. It is used in surgical and diagnosis applications by various end users such as hospitals, ENT clinics, and others. The increase in the prevalence of ear-related diseases is expected to propel the growth of the otoscope market going forward.The prevalence of ear-related diseases refers to the frequency or proportion of individuals within a population affected by conditions or disorders related to the ear. Due to genetic predisposition, poor hygiene practices, allergies, and infections, the prevalence of ear-related diseases is increasing.Otoscopes help reduce ear-related diseases by aiding in early detection, accurate diagnosis, and appropriate treatment. For instance, in February 2023, according to the World Health Organization, a Switzerland-based international public health organization, around 5% of the world population have disabling hearing loss, among which 432 million are adult patients and 34 million are children who have hearing loss.Further, it is estimated that in 2050, the number of people affected by hearing loss will reach up to 700 million. Therefore, the increasing prevalence of ear-related diseases is driving the otoscope market. A Integration of AI-based algorithms with digital forms of otoscopes is a key trend gaining popularity in the otoscope market.Major companies operating in the otoscope market are integrating AI-based algorithms with digital forms of otoscopes to sustain their position in the market. For instance, in October 2020, TytoCare, a US-based AI-powdered telehealth medical examination services provider company, integrated diagnostic AI components into an at-home telehealth kit.This Typo Care product consists of a mobile device with an application with modular attachments for health examinations, including an otoscope for ears and a stethoscope for lungs, heart, and throat. This product enables patients and clinicians to share diagnostic examination data and schedule medical appointments. In December 2021, Baxter International Inc., a US-based healthcare company, acquired Hill-Rom Holdings Inc. for $10.5 billion. This acquisition broadens, diversifies, and enriches Baxter’s portfolio by adding health innovation, medical technology, and otoscope diagnostic sets and enhancing the research and development capabilities of Hill-Rom Holdings Inc. Hill-Rom Holdings, Inc. is a US-based manufacturer of surgical solutions, patient support systems, and front-line care products, including otoscopes. The countries covered in the otoscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The otoscopes market research report is one of a series of new reports that provides otoscopes market statistics, including otoscopes industry global market size, regional shares, competitors with a otoscopes market share, detailed otoscopes market segments, market trends and opportunities, and any further data you may need to thrive in the otoscopes industry. This otoscopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

CellScope Frequently Asked Questions (FAQ)

  • When was CellScope founded?

    CellScope was founded in 2010.

  • Where is CellScope's headquarters?

    CellScope's headquarters is located at 5537 Claremont Avenue, Oakland.

  • What is CellScope's latest funding round?

    CellScope's latest funding round is Seed VC.

  • How much did CellScope raise?

    CellScope raised a total of $1.02M.

  • Who are the investors of CellScope?

    Investors of CellScope include Khosla Ventures, Rock Health and Plug and Play Accelerator.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.